130 related articles for article (PubMed ID: 1272359)
1. Letter: Reliable chemical diagnosis of neuroblastoma better than screening.
Bray PF; Wu JT; Myers GG
N Engl J Med; 1976 Jul; 295(4):230-1. PubMed ID: 1272359
[No Abstract] [Full Text] [Related]
2. [Characteristics of urinary excretion of vanilmandelic and homovanillic acids in cases of neuroblastoma during therapy].
Lamedica G; Falcone R; De Bernardi B; Canini S
Minerva Pediatr; 1978 Jan; 30(2):137-46. PubMed ID: 642879
[No Abstract] [Full Text] [Related]
3. Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors.
LaBrosse EH; Com-Nougué C; Zucker JM; Comoy E; Bohuon C; Lemerle J; Schweisguth O
Cancer Res; 1980 Jun; 40(6):1995-2001. PubMed ID: 7371035
[No Abstract] [Full Text] [Related]
4. More on gas-liquid chromatographic determination of homovanillic and vanillylmandelic acids in urine from cases of neuroblastoma.
Melchert HU; Hoffmeister H
Clin Chem; 1978 May; 24(5):842-3. PubMed ID: 647929
[No Abstract] [Full Text] [Related]
5. Simple method for the determination of homovanillic acid and vanillylmandelic acid in urine by high-performance liquid chromatography.
Yoshida A; Yoshioka M; Sakia T; Tamura Z
J Chromatogr; 1982 Jan; 227(1):162-7. PubMed ID: 7056807
[No Abstract] [Full Text] [Related]
6. Urinary 3-methoxy-4-hydroxyphenylacetic (homovanillic) and 3-methoxy-4-hydroxymandelic (vanillylmandelic) acids: gas-liquid chromatographic methods and experience with 13 cases of neuroblastoma.
Brewster MA; Berry DH; Moriarty M
Clin Chem; 1977 Dec; 23(12):2247-9. PubMed ID: 923075
[TBL] [Abstract][Full Text] [Related]
7. Direct determination of urinary vanillylmandelic acid and homovanillic acid by high-performance liquid chromatography on an anion-exchange column.
Kodama K; Nakata T; Aoyama M
J Chromatogr; 1984 Nov; 311(2):369-74. PubMed ID: 6520184
[No Abstract] [Full Text] [Related]
8. Assessment of the diurnal variations in urinary homovanillic and vanillylmandelic acid excretion for the diagnosis and follow-up of patients with neuroblastoma.
Tuchman M; Robison LL; Maynard RC; Ramnaraine ML; Krivit W
Clin Biochem; 1985 Jun; 18(3):176-9. PubMed ID: 4039636
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy of radically unresectible neuroblastoma in the 1st 18 months of life. Importance of quantitative determination of dopamine, vanilmandelic and homovanillic acids].
Zeder B; Käser H; Wagner HP
Helv Paediatr Acta; 1974 Jun; 29(2):95-104. PubMed ID: 4436123
[No Abstract] [Full Text] [Related]
10. Urinary levels of vanilmandelic acid and homovanillic acid determined by high-speed liquid chromatography.
Yoshida A; Yoshioka M; Yamazaki T; Sakai T; Tamura Z
Clin Chim Acta; 1976 Dec; 73(2):315-20. PubMed ID: 1000851
[TBL] [Abstract][Full Text] [Related]
11. Letter: Determination of vanilmandelic acid and homovanillic acid in urine by gas chromatography.
Yoshiue S; Yoshioka M; Tamura Z
Chem Pharm Bull (Tokyo); 1975 Nov; 23(11):3040-1. PubMed ID: 1218444
[No Abstract] [Full Text] [Related]
12. Liquid-chromatographic analysis for urinary 4-hydroxy-3-methoxymandelic acid and 4-hydroxy-3-methoxyphenylacetic acid, and its use in investigation of neural crest tumors.
Soldin SJ; Hill JG
Clin Chem; 1981 Mar; 27(3):502-3. PubMed ID: 7471405
[No Abstract] [Full Text] [Related]
13. IV. Estimation by gas chromatography of urinary homovanillic acid and vanilmandelic acid in neuroblastoma.
Williams CM; Greer M
Methods Med Res; 1970; 12():106-14. PubMed ID: 5432487
[No Abstract] [Full Text] [Related]
14. Method of measurement of urinary homovanillic acid and vanillylmandelic acid by gas chromatography-mass spectrometry suitable for neuroblastoma screening.
Seviour JA; McGill AC; Dale G; Craft AW
J Chromatogr; 1988 Nov; 432():273-7. PubMed ID: 3220894
[No Abstract] [Full Text] [Related]
15. Value of random urinary homovanillic acid and vanillylmandelic acid levels in the diagnosis and management of patients with neuroblastoma: comparison with 24-hour urine collections.
Tuchman M; Morris CL; Ramnaraine ML; Bowers LD; Krivit W
Pediatrics; 1985 Feb; 75(2):324-8. PubMed ID: 3969335
[TBL] [Abstract][Full Text] [Related]
16. Results of mass screening for neuroblastoma in Sapporo, Japan.
Takeda T; Nishi M; Shimada M; Nakadate H; Hatae Y; Naito H; Hanai J; Kawai T; Takasugi N
Prog Clin Biol Res; 1991; 366():595-601. PubMed ID: 2068178
[No Abstract] [Full Text] [Related]
17. Screening for neuroblastoma in North America--preliminary results from the Quebec project.
Woods WG; Tuchman M; Lemieux B
Prog Clin Biol Res; 1991; 366():585-94. PubMed ID: 2068177
[No Abstract] [Full Text] [Related]
18. A simple coloured-paper thin-layer chromatography test as a backup procedure for vanillylmandelic acid and homovanillic acid evaluation in a neuroblastoma screening program.
Mathieu P; Philip T; Greffe J; Montegue A; Lacroix C
Clin Chim Acta; 1993 Nov; 220(2):229-32. PubMed ID: 8111967
[No Abstract] [Full Text] [Related]
19. Screening for neuroblastoma.
Norman MG; Dimmick JE; Taylor GP; Teasdale M
Lancet; 1987 Sep; 2(8558):565-6. PubMed ID: 2887853
[No Abstract] [Full Text] [Related]
20. [Paracetamol interference with vanilmandelic and homovanillic acid quantification by the Bio-Rad HPLC kit].
Drouard-Troalen L; Assicott MJ; Bonnay MM
Ann Biol Clin (Paris); 2002; 60(5):626-7. PubMed ID: 12405118
[No Abstract] [Full Text] [Related]
[Next] [New Search]